A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis | MicrobiomeTrials
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-08-20Est. Completion: 2027-12-31
Enrollment target: 90 participants
Locations
Syneos Health Miami, Miami, Florida, United States